Sole Supply - Pending Changes Quick Reference *** Sorted by Sole Supply Start Date *** Chemical Brand Name Type, Strength, Pack Size Pharmacode New Tender Date of New Sole Supply Brands to be & Supplier delisted Reference Start Date for tender Underlined Pharmacode in BOLD Pricing of New pack sizes become available once Non-tend
Microsoft word - managing constipation in patients receiving palliative cancer care final october 2012.docCoastal West Sussex
Clinical Commissioning Group
Managing Constipation in Patients Receiving Palliative Cancer Care1
How should I treat constipation?
The Rome III diagnostic criteria* state that functional constipation must include two or more of the following:
straining during at least 25% of defecations, lumpy or hard stools in at least 25% of defecations, sensation of
incomplete evacuation for at least 25% of defecations, sensation of anorectal obstruction/blockage for at least 25% of
defecations, manual manoeuvres to facilitate at least 25% of defecations (e.g. digital evacuation, support of the pelvic
floor), fewer than three defecations per week. Loose stools are rarely present without the use of laxatives. There
should be insufficient criteria for irritable bowel syndrome. *criteria should be fulfilled for the last 3 months with
symptom onset at least 6 months prior to diagnosis.
Exclude or manage bowel obstruction, anal fissure, painful haemorrhoids and local tumour. Begin treatment by relieving any faecal loading/impaction. Encourage the person to increase their physical activity and their fluid and dietary fibre intake if appropriate. Ensure adequate privacy and sufficient help to get to the toilet. Start treatment with a combination of a stimulant plus a softening laxative (see combinations below). If colic is a problem, use a softening laxative for a few days and then add in the stimulant. A stimulant laxative alone may be sufficient if the rectum is full of soft faeces. However, a softening laxative will often be required later on, particularly if the person is taking any constipating drugs (for example opioids). Titrate the dose every few days to achieve comfortable defaecation. Comfort is more important than the frequency or number of stools. It may be necessary to exceed the licensed dose and frequency. Adjust the laxative dose in line with the opioid dose.
Approximate equivalent stimulant plus softening laxative combinations
Three senna tablets (or 15ml senna syrup) plus 300mg docusate Three senna tablets (or 15ml senna syrup) plus 15ml lactulose Six co-danthramer capsules (or 30ml co-danthramer syrup) Four co-danthramer strong capsules (or 10ml co-danthramer strong syrup)
What should I do if the response to laxatives is insufficient?
Check that the dose of stimulant and softening laxative has been adequately titrated. Adjust the dose of stimulant to produce defaecation without colic. Adjust the dose of softener to produce a comfortable stool. Higher and more frequent doses than specified by the product licence may be needed. The laxative dose also needs to increase with increases in opioid dose. Consider whether additional short-term treatment for faecal loading/impaction is needed. 1 PRODIGY – Palliative cancer care – constipation. Available at: http://prodigy.clarity.co.uk/constipation/management/scenario_adults#-317747 <accessed 16/05/12> Consider switching to a macrogol or adding in a prokinetic agent such as metoclopramide, domperidone, or erythromycin 250-500mg four times a day (off-label use) – exclude obstruction before use. If passing a stool is painful, exclude (or manage) anal fissure, painful haemorrhoids, or local tumour. If neurological gut dysmotility is present, consider a weekly dose of sodium picosulfate. Neurological gut dysmotility is more likely in people with other neurological symptoms or signs, diabetes, small cell lung cancer, a history of chemotherapy with vinca alkaloids or platinum, a history of long term laxative abuse, or resistance to usual laxatives. Seek specialist advice if constipation still persists despite these measures – a switch to another possibly less constipating opioid may be considered (for example fentanyl, methadone) but dose conversion may be difficult so specialist advice is advised.
What doses of laxative may be needed in palliative care?
Licensed dose (adults)
Dose that may be needed in
palliative care (off licence)
capsules or 75/1000mg suspension) Co-danthrusate (dantron/docusate For high faecal loading/impaction: 8 sachets dissolved in 1 litre of water and drunk within 6 hours. Limit to 2 sachets (250 ml/hour) in heart failure 15-22.5mg (2-3 tablets) three times a day
Links to Accepted Guidance
Palliative Care Adult Network Guidelines on Constipation
The information contained in this guidance has been taken from the PRODIGY website on managing constipation in palliative cancer care.
Journal of Insect Physiology 54 (2008) 17–24Eicosanoids mediate melanotic nodulation reactions to viral infection inlarvae of the parasitic wasp, Pimpla turionellaeYonca Durmus-a, Ender Bu¨yu¨kgu¨zela, Burcin Terzia, Hasan Tunazb,David Stanleyc,Ã, Kemal Bu¨yu¨kgu¨zelaaDepartment of Biology, Faculty of Arts and Science, Karaelmas University, Zonguldak, TurkeybDepartment of Plant